161 related articles for article (PubMed ID: 38731953)
1. Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1.
Goto K; Fujiwara-Tani R; Nukaga S; Miyagawa Y; Kawahara I; Nishida R; Ikemoto A; Sasaki R; Ogata R; Kishi S; Luo Y; Fujii K; Ohmori H; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731953
[TBL] [Abstract][Full Text] [Related]
2. miR-708 affords protective efficacy in anoxia/reoxygenation-stimulated cardiomyocytes by blocking the TLR4 signaling via targeting HMGB1.
Zhang S; Wang Y; Wang P; Xuan J
Mol Cell Probes; 2020 Dec; 54():101653. PubMed ID: 32866662
[TBL] [Abstract][Full Text] [Related]
3. Berberine up-regulates miR-340-5p to protect myocardial ischaemia/reperfusion from HMGB1-mediated inflammatory injury.
Long T; Pan W; Li F; Sheikh SA; Xie Q; Zhang C
ESC Heart Fail; 2023 Apr; 10(2):931-942. PubMed ID: 36453191
[TBL] [Abstract][Full Text] [Related]
4. Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway.
Ding HS; Yang J; Yang J; Guo X; Tang YH; Huang Y; Chen Z; Fan ZX; Huang CX
Mol Biol Rep; 2021 May; 48(5):3893-3901. PubMed ID: 34032975
[TBL] [Abstract][Full Text] [Related]
5. Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy.
Gendy AM; Elnagar MR; Allam MM; Mousa MR; Khodir AE; El-Haddad AE; Elnahas OS; Fayez SM; El-Mancy SS
Biomed Pharmacother; 2022 Jan; 145():112122. PubMed ID: 34489150
[TBL] [Abstract][Full Text] [Related]
6. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways.
Arab HH; Al-Shorbagy MY; Saad MA
Chem Biol Interact; 2021 Feb; 335():109368. PubMed ID: 33412153
[TBL] [Abstract][Full Text] [Related]
7. Effect of Shenqi Yangxin decoction on high mobility group box 1 and inflammatory signal pathway in a rat model of dilated cardiomyopathy.
Shen L; Xing Q; Lu S; Zhou Y; Zhou C; Li L
J Tradit Chin Med; 2018 Dec; 38(6):862-871. PubMed ID: 32186133
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation.
Cao DW; Liu MM; Duan R; Tao YF; Zhou JS; Fang WR; Zhu JR; Niu L; Sun JG
Acta Pharmacol Sin; 2020 Jan; 41(1):22-33. PubMed ID: 31431734
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of glycyrrhizin on coronary microembolization-induced myocardial dysfunction in rats.
Yuan Y; Li B; Peng W; Xu Z
Pharmacol Res Perspect; 2021 Feb; 9(1):e00714. PubMed ID: 33507583
[TBL] [Abstract][Full Text] [Related]
12. CCCTC-binding factor-mediated microRNA-340-5p suppression aggravates myocardial injury in rats with severe acute pancreatitis through activation of the HMGB1/TLR4 axis.
Gao Y; Gao Y; Niu Z; Liu J; Feng H; Sun J; Wang L; Pan L
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):306-315. PubMed ID: 35238277
[TBL] [Abstract][Full Text] [Related]
13. MiR-129-5p protects against myocardial ischemia-reperfusion injury via targeting HMGB1.
Chen ZX; He D; Mo QW; Xie LP; Liang JR; Liu L; Fu WJ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4440-4450. PubMed ID: 32373982
[TBL] [Abstract][Full Text] [Related]
14. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway.
Zhang L; Yang X; Jiang G; Yu Y; Wu J; Su Y; Sun A; Zou Y; Jiang H; Ge J
Int J Mol Med; 2019 Sep; 44(3):885-892. PubMed ID: 31524228
[TBL] [Abstract][Full Text] [Related]
16. miR-129-5p alleviates LPS-induced acute kidney injury via targeting HMGB1/TLRs/NF-kappaB pathway.
Huang X; Hou X; Chuan L; Wei S; Wang J; Yang X; Ru J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107016. PubMed ID: 33039954
[TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K/Akt signalling pathway.
Liu H; Liu W; Qiu H; Zou D; Cai H; Chen Q; Zheng C; Xu D
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1527-1539. PubMed ID: 31853618
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-kB signaling pathway.
Liu AH; Wu YT; Wang YP
Brain Res Bull; 2017 Jun; 132():139-149. PubMed ID: 28528202
[TBL] [Abstract][Full Text] [Related]
19. The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury.
Xue J; Ge H; Lin Z; Wang H; Lin W; Liu Y; Wu G; Xia J; Zhao Q
J Cell Mol Med; 2019 Apr; 23(4):2849-2862. PubMed ID: 30784177
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1-RAGE/TLR4-NF-κB/AKT pathway.
Hu Z; Xiao M; Cai H; Li W; Fang W; Long X
J Cell Mol Med; 2022 Feb; 26(3):925-936. PubMed ID: 34953035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]